title: Photosensitizer conjugated iron oxide nanoparticles for simultaneous in vitro magneto-fluorescent imaging guided photodynamic therapy.
abstract: In this study, photosensitizer conjugated iron oxide nanoparticles were strategically designed and prepared for simultaneous PDT and dual-mode fluorescence/MR imaging. The MRI contrast agent Fe3O4 was modified by APTES to functionalize the surface and further to link with heparin-pheophorbide-A conjugates.
authors.affiliation: Department of Green Bioengineering, Korea National University of Transportation, Chungju 380-702, South Korea. leeyk@ut.ac.kr.
authors.forename: Md
authors.initials: M
authors.lastname: Nafiujjaman
authors.forename: Vishnu
authors.initials: V
authors.lastname: Revuri
authors.forename: Md
authors.initials: M
authors.lastname: Nurunnabi
authors.forename: Kwang Jae
authors.initials: KJ
authors.lastname: Cho
authors.forename: Yong-Kyu
authors.initials: YK
authors.lastname: Lee
mesh_terms: D016923:Cell Death / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002734:Chlorophyll / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D003287:Contrast Media / Q000737:chemistry; D005290:Ferric Compounds / Q000737:chemistry* / Q000494:pharmacology; D005453:Fluorescence; D006493:Heparin / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D007624:KB Cells; D008279:Magnetic Resonance Imaging; D053758:Nanoparticles / Q000737:chemistry*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000737:chemistry* / Q000494:pharmacology
chemical_list: D003287:Contrast Media; D005290:Ferric Compounds; D017319:Photosensitizing Agents; D002734:Chlorophyll; C000499:ferric oxide; D006493:Heparin; C032623:pheophorbide a